+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

2019 Febrile Neutropenia Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4767472
  • Report
  • 94 pages
  • VPA Research
1 of 4

FEATURED COMPANIES

  • Amgen Inc
  • Apotex Inc
  • Astellas Pharma Inc
  • Coherus BioSciences Inc
  • F. Hoffmann-La Roche Ltd
  • Novartis AG
  • MORE
The global clinical trial report- “2019 Febrile Neutropenia Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Febrile Neutropenia. It presents in-depth analysis of Febrile Neutropenia clinical trials across markets and companies. The research work is for providing complete understanding into trends in Febrile Neutropenia.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Febrile Neutropenia clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Febrile Neutropenia

The research work is prepared through extensive and continuous research on Febrile Neutropenia trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Febrile Neutropenia patients are identified
  • The report includes panorama of Febrile Neutropenia clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Febrile Neutropenia clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Amgen Inc
  • Apotex Inc
  • Astellas Pharma Inc
  • Coherus BioSciences Inc
  • F. Hoffmann-La Roche Ltd
  • Novartis AG
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Febrile Neutropenia Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Febrile Neutropenia Clinical Trials by Region
2.2.2 Average Enrollment of Febrile Neutropenia Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Febrile Neutropenia Treatment, 2019

3. Region wise Febrile Neutropenia Clinical Trials
3.1 Asia Pacific Febrile Neutropenia Clinical Trials by Country
3.2 Europe Febrile Neutropenia Clinical Trials by Country
3.3 North America Febrile Neutropenia Clinical Trials by Country
3.4 Middle East and Africa Febrile Neutropenia Clinical Trials by Country
3.5 South and Central America Febrile Neutropenia Clinical Trials by Country

4. Febrile Neutropenia Clinical Trial Trends
4.1 Start Year wise Febrile Neutropenia Clinical Trials
4.2 Phase wise Febrile Neutropenia Clinical Trials
4.3 Trial Status wise Febrile Neutropenia Clinical Trials
4.4 Trial Type wise Febrile Neutropenia Clinical Trials

5. Febrile Neutropenia Average Enrollment Trends
5.1 Average Enrollment in Febrile Neutropenia Trials by Year
5.2 Average Enrollment in Febrile Neutropenia Trials by Phase
5.3 Average Enrollment in Febrile Neutropenia Trials by Status
5.4 Average Enrollment in Febrile Neutropenia Trials by Type of Trial

6. Companies Participating in Febrile Neutropenia Clinical Trials
6.1 Febrile Neutropenia Trials by Sponsor Type
6.2 Febrile Neutropenia Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Febrile Neutropenia Trials- Phase 1
7.2 Febrile Neutropenia Trials- Phase 2
7.3 Febrile Neutropenia Trials- Phase 3
7.4 Febrile Neutropenia Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Febrile Neutropenia Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Febrile Neutropenia Clinical Trials and Enrolment
Figure 5: Europe - Country wise Febrile Neutropenia Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Febrile Neutropenia Clinical Trials and Enrolment
Figure 7: North America - Country wise Febrile Neutropenia Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Febrile Neutropenia Clinical Trials and Enrolment
Figure 9: Febrile Neutropenia Clinical Trials by Phase
Figure 10: Febrile Neutropenia Clinical Trials by Trial Status
Figure 11: Febrile Neutropenia Clinical Trials by Type
Figure 12: Febrile Neutropenia Clinical Trials by Sponsor Type
Figure 13: Febrile Neutropenia Clinical Trials by Leading Sponsors
Figure 14: Febrile Neutropenia Average Enrollment by Phase
Figure 15: Febrile Neutropenia Average Enrollment by Trial Status
Figure 16: Febrile Neutropenia Average Enrollment by Type
Figure 17: Febrile Neutropenia- Average Enrolment by Type of Sponsors
Figure 18: Febrile Neutropenia- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Febrile Neutropenia Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Febrile Neutropenia Clinical Trials and Enrolment
Table 5: Europe - Country wise Febrile Neutropenia Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Febrile Neutropenia Clinical Trials and Enrolment
Table 7: North America - Country wise Febrile Neutropenia Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Febrile Neutropenia Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Febrile Neutropenia Average Enrollment by Phase
Table 15: Febrile Neutropenia Average Enrollment by Trial Status
Table 16: Febrile Neutropenia Average Enrollment by Type
Table 17: Febrile Neutropenia- Average Enrolment by Type of Sponsors
Table 18: Febrile Neutropenia- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Accelsiors CRO & Consultancy Services
  • Amgen Inc
  • Apotex Inc
  • Astellas Pharma Inc
  • Coherus BioSciences Inc
  • F. Hoffmann-La Roche Ltd
  • Novartis AG
  • Otsuka Holdings Co Ltd
  • Pfizer Inc
  • Teva Pharmaceutical Industries Ltd
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4767472
Adroll
adroll